Norsk Patenttidende nr 09/05 - Patentstyret
Norsk Patenttidende nr 09/05 - Patentstyret
Norsk Patenttidende nr 09/05 - Patentstyret
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
allment tilgjengelige patentsøknader (A) 20<strong>05</strong>.02.28 - <strong>nr</strong> <strong>09</strong>/<strong>05</strong><br />
(51) Klasse : A61K 031/397<br />
A61K 0<strong>09</strong>/48<br />
A61P 025/18<br />
A61P 025/16<br />
(21) Søknads<strong>nr</strong> : 20042781<br />
(22) Inndag : 2004.07.01<br />
(41) Allm.tilgj : 2004.<strong>09</strong>.20<br />
(30) Prioritet : 2001.12.21, FR, 0116638<br />
(86) Int.inndag : 2002.12.20<br />
(86) Int.søknads<strong>nr</strong> : PCT/FR02/04514<br />
(24) Løpedag 2002.12.20<br />
(71) Søker<br />
Aventis Pharma SA , 20, avenue Raymond Aron, 92160,<br />
Antony, FR<br />
(74) Fullmektig<br />
Zacco Norway AS , Postboks 765 Sentrum, 0106 OSLO,<br />
NO<br />
(72) Oppfinner<br />
Sophie Coté, 22, rue Pasteur, ANTONY, 92160, FR<br />
Bobineau Valérie, 14, bis rue du Clos de Massy,<br />
ANTONY, 92160, FR<br />
Peracchia Maria-Teresa, 18, rue Cuvier, PARIS, 750<strong>05</strong>,<br />
FR<br />
(54) Benevnelse<br />
Farmasøytiske sammensetninger basert på<br />
azetidinderivater<br />
(51) Klasse : A61K 031/496<br />
A61P 025/00<br />
(21) Søknads<strong>nr</strong> : 20043902<br />
(22) Inndag : 2004.<strong>09</strong>.17<br />
(41) Allm.tilgj : 2004.<strong>09</strong>.17<br />
(30) Prioritet : 2002.02.20, US, 358806<br />
2002.02.12, US, 359038<br />
2002.02.27, US, 360459<br />
(86) Int.inndag : 2003.02.17<br />
(86) Int.søknads<strong>nr</strong> : PCT/IB03/00642<br />
(24) Løpedag 2003.02.17<br />
(71) Søker<br />
Pfizer Products Inc , Eastern Point Road, CT06340<br />
GROTON, US<br />
(74) Fullmektig<br />
Zacco Norway AS , Postboks 765 Sentrum, 0106 OSLO,<br />
NO<br />
(72) Oppfinner<br />
Frank Robert Busch, c/o Pfizer Global Research and<br />
Development, Eastern Point Road, GROTON, CT06340,<br />
US<br />
Harry Ralph Howard Jr, c/o Pfizer Global R & D, Eastern<br />
Point Road, GROTON, CT06340, US<br />
Adam Worth Grobin, 1<strong>09</strong> Cardiff Place, CHAPPEL HILL,<br />
NC27516, US<br />
Kyle Robert Leeman, c/o Pfizer Global Research and<br />
Development, Eastern Point Road, GROTON, CT06340,<br />
US<br />
(54) Benevnelse<br />
Kontrollert syntese av ziprasidon og sammensetninger<br />
derav<br />
(51) Klasse : A61K 031/404<br />
A61K 0<strong>09</strong>/20<br />
A61P 001/00<br />
(21) Søknads<strong>nr</strong> : 20042779<br />
(22) Inndag : 2004.07.01<br />
(41) Allm.tilgj : 2004.<strong>09</strong>.17<br />
(30) Prioritet : 2001.12.21, WO, 01403339<br />
(86) Int.inndag : 2002.12.20<br />
(86) Int.søknads<strong>nr</strong> : PCT/EP02/14674<br />
(24) Løpedag 2002.12.20<br />
(71) Søker<br />
Novartis AG , Lichtstrasse 35, 4<strong>05</strong>6 BASEL, CH<br />
(74) Fullmektig<br />
Zacco Norway AS , Postboks 765 Sentrum, 0106 OSLO,<br />
NO<br />
(72) Oppfinner<br />
Jérome Aubert, 4, rue de la Féculerie, JARGEAU, 45150,<br />
FR<br />
Vitzing Christian, 39, rue de Pommard, PARIS, 75012, FR<br />
(54) Benevnelse<br />
Partiell 5HT4-agonistholdige farmsaøytiske<br />
sammensetninger<br />
(51) Klasse : A61K 031/5025<br />
A61K 0<strong>09</strong>/14<br />
A61P 029/00<br />
(21) Søknads<strong>nr</strong> : 20043889<br />
(22) Inndag : 2004.<strong>09</strong>.16<br />
(41) Allm.tilgj : 2004.<strong>09</strong>.16<br />
(30) Prioritet : 2002.03.15, GB, 0206200<br />
(86) Int.inndag : 2003.03.13<br />
(86) Int.søknads<strong>nr</strong> : PCT/EP03/02698<br />
(24) Løpedag 2003.03.13<br />
(71) Søker<br />
Glaxo Group Ltd , Glaxo Wellcome House, Berkeley<br />
Avenue, UB60NN GREENFORD, MIDDLESEX, GB<br />
(74) Fullmektig<br />
Bryn Aarflot AS , Postboks 449 Sentrum, 0104 OSLO, NO<br />
(72) Oppfinner<br />
Simon Joseph Holland, c/o GlaxoSmithKline, New<br />
Frontiers Science Park South, Third Avenue, HARLOW,<br />
ESSEX, CM195AW, GB<br />
Jonathan Appleby, c/o GlaxoSmithKline, New Frontiers<br />
Science Park South, Third Avenue, HARLOW, ESSEX,<br />
CM195AW, GB<br />
Martin Rolfe Hill, c/o GlaxoSmithKline, New Frontiers<br />
Science Park South, Third Avenue, HARLOW, ESSEX,<br />
CM195AW, GB<br />
Stephanie Lynn Pearson, c/o GlaxoSmithKline, New<br />
Frontiers Science Park South, Third Avenue, HARLOW,<br />
ESSEX, CM19SAW, GB<br />
(54) Benevnelse<br />
Farmasøytiske blandinger omfattende 2-(4-etoksy-fenyl)-<br />
3-(4-metansulfonyl-fenyl)-pyrazolo' 1,5-bipyridazin i<br />
nanopartikkelform<br />
44
Change language